Harry Clarke to Male
This is a "connection" page, showing publications Harry Clarke has written about Male.
Connection Strength
0.108
-
Ductal prostatic adenocarcinoma: magnetic resonance imaging documenting the effect of hormone-radiotherapy. J Coll Physicians Surg Pak. 2014 Mar; 24 Suppl 1:S55-6.
Score: 0.026
-
Combination 5-alpha-reductase inhibitors and alpha-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2008 Jul; 9(4):291-4.
Score: 0.017
-
Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Can J Urol. 2007 Dec; 14 Suppl 1:24-7.
Score: 0.017
-
Prostate cancer: screening and treatment options. J S C Med Assoc. 2003 Apr; 99(4):85-7.
Score: 0.012
-
Six Weeks of Fluoroquinolone Antibiotic Therapy for Patients With Elevated Serum Prostate-specific Antigen Is Not Clinically Beneficial: A Randomized Controlled Clinical Trial. Urology. 2016 Apr; 90:32-7.
Score: 0.007
-
Penile cancer: an analysis of socioeconomic factors at a southeastern tertiary referral center. Can J Urol. 2011 Feb; 18(1):5524-8.
Score: 0.005
-
Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate. Urology. 2010 Nov; 76(5):1162-7.
Score: 0.005
-
Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):1010-6.
Score: 0.005
-
Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer. Urology. 2008 Jun; 71(6):1177-80.
Score: 0.004
-
Multiple/bilateral renal tumors in patients with Birt-Hogg-Dub? syndrome. Int Urol Nephrol. 2007; 39(4):995-9.
Score: 0.004
-
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003 Dec 18; 349(25):2387-98.
Score: 0.003
-
Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia. Urology. 2002 Jan; 59(1):63-7.
Score: 0.003